<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kanasuwan A</submitter><funding>National Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy</funding><funding>the National Research Council of Thailand under Molecular Probes for Imaging Research Net-work</funding><pagination>3614</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9959096</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(4)</volume><pubmed_abstract>α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> Nicotinic acetylcholine receptor (nAChR) has been recognized as an emerging biomarker for the early detection of drug addiction. Herein, α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> nAChR ligands were designed and synthesized to improve the binding affinity and selectivity of two lead compounds, &lt;b>(&lt;i>S&lt;/i>)&lt;/b>-&lt;b>QND8&lt;/b> and &lt;b>(&lt;i>S&lt;/i>)&lt;/b>-&lt;b>T2&lt;/b>, for the development of an α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> nAChR tracer. The structural modification was achieved by retaining the key features and expanding the molecular structure with a benzyloxy group to increase the lipophilicity for blood-brain barrier penetration and to extend the ligand-receptor interaction. The preserved key features are a fluorine atom for radiotracer development and a &lt;i>p&lt;/i>-hydroxyl motif for ligand-rec</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Selective α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> Nicotinic Acetylcholine Receptor Ligand as a Potential Tracer for Drug Addiction.</pubmed_title><pmcid>PMC9959096</pmcid><funding_grant_id>NRCT: N10A650046</funding_grant_id><funding_grant_id>N10A650046</funding_grant_id><pubmed_authors>Chotipanich C</pubmed_authors><pubmed_authors>Arunrungvichian K</pubmed_authors><pubmed_authors>Vajragupta O</pubmed_authors><pubmed_authors>Kanasuwan A</pubmed_authors><pubmed_authors>Sarasamkan J</pubmed_authors><pubmed_authors>Deuther-Conrad W</pubmed_authors><pubmed_authors>Chongruchiroj S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Selective α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> Nicotinic Acetylcholine Receptor Ligand as a Potential Tracer for Drug Addiction.</name><description>α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> Nicotinic acetylcholine receptor (nAChR) has been recognized as an emerging biomarker for the early detection of drug addiction. Herein, α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> nAChR ligands were designed and synthesized to improve the binding affinity and selectivity of two lead compounds, &lt;b>(&lt;i>S&lt;/i>)&lt;/b>-&lt;b>QND8&lt;/b> and &lt;b>(&lt;i>S&lt;/i>)&lt;/b>-&lt;b>T2&lt;/b>, for the development of an α&lt;sub>3&lt;/sub>β&lt;sub>4&lt;/sub> nAChR tracer. The structural modification was achieved by retaining the key features and expanding the molecular structure with a benzyloxy group to increase the lipophilicity for blood-brain barrier penetration and to extend the ligand-receptor interaction. The preserved key features are a fluorine atom for radiotracer development and a &lt;i>p&lt;/i>-hydroxyl motif for ligand-rec</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-04-08T12:49:29.565Z</modification><creation>2024-11-20T00:46:59.727Z</creation></dates><accession>S-EPMC9959096</accession><cross_references><pubmed>36835028</pubmed><doi>10.3390/ijms24043614</doi></cross_references></HashMap>